Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) shot up 1.8% during mid-day trading on Tuesday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8%
The company has a market capitalization of C$18.19 million, a price-to-earnings ratio of -1.21 and a beta of 1.22. The company has a 50 day simple moving average of C$0.58 and a 200 day simple moving average of C$0.58.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Further Reading
- Five stocks we like better than Acasti Pharma
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
- Sociedad Química y Minera’s Lithium Boom Is Back, But Iodine Steals the Show
- Forget Chips: These 3 Stocks Are Building the AI Data Center Boom
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}